Cited by 22Cannabis and Cannabinoid ResearchUrinary Bladder and Prostate ResearchSexual function and dysfunction studies

A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome

Open access
Tripp, Dean A, Nickel, J Curtis, Katz, Laura, Krsmanovic, Adrijana, Ware, Mark A, Santor, Darcy·2014·Canadian Urological Association Journal

Abstract

Introduction: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a chronic pelvic pain condition largely refractory to treatment. Cannabis (marijuana) use has been reported for a wide variety of chronic pain conditions, but no study has examined prevalence of cannabis use, symptom benefit or side effects, or frequency in CP/CPPS.Methods: Participants were recruited from an outpatient CP/CPPS urology clinic (n = 98) and online through the Prostatitis Foundation website (n = 244). Participants completed questionnaires (demographics, CP/CPPS, depression, cannabis).Results: The clinic sample included Canadian patients and the online sample included primarily American patients. Due to differences, groups were examined separately. Almost 50% of respondents reported using cannabis (clinic n = 49; online n = 89). Of the cannabis users, 36.8% of clinic and 75% of online respondents reported that it improved their symptoms. Most of the respondents (from the clinic and online groups) reported that cannabis improved their mood, pain, muscle spasms, and sleep. However, they did not note any improvements for weakness, fatigue, numbness, ambulation, and urination. Overall, the effectiveness of cannabis for CP/CPPS was “somewhat/very effective” (57% clinic; 63% online). There were no differences between side effects or choice of consumptionand most reported using cannabis rarely.Conclusions: These are the first estimates in men suffering from CP/CPPS and suggest that while cannabis use is prevalent, its medical use and benefit are unknown. This is an understudied area and the benefit or hazard for cannabis use awaits further study.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5489/cuaj.2268

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the five studies on nausea in chronic pain, each involved whole plant cannabis in inhaled or oral formats, and patients reported moderate relief.

    “Each study involved whole plant cannabis in inhaled or oral formats, with patients reporting moderate relief.”

    From Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions (2024) · cites this paper as [85]

    The Results report that some men with chronic prostatitis/chronic pelvic pain syndrome said cannabis made nausea 'slightly/much better'; Table 3 gives 41.7% in the clinic group and 52.6% in the online group. The Results and Table 4 show that herbal cannabis was commonly used and smoking was a leading preferred method, but they do not establish that patients used only inhaled or oral formats, or that their nausea relief was specifically moderate. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tripp, D. A., Nickel, J. C., Katz, L., Krsmanovic, A., Ware, M. A., & Santor, D.
Affiliations
  • Queen's University (CA)
  • McGill University Health Centre (CA)
  • University of Ottawa (CA)
Venue
Canadian Urological Association Journal
Published
2014-12-15
Volume
8
Issue
11-12
Pages
901
ISSN
  • 1911-6470 (ISSN-L)
  • 1920-1214
OpenAlex
W2076717220
Cited by
22
References
25
Citations by year
2026: 1 · 2024: 1 · 2023: 3 · 2021: 2 · 2020: 6 · 2019: 2 · 2018: 1 · 2017: 5 · 2016: 1
FWCI
1.46
Type
journal article
Language
en
Open access
Locations
  • Canadian Urological Association Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
Keywords
cannabis use, cannabis, chronic prostatitis, cannabis side effects, prevalence, men, pain management, mood, sleep, muscle spasm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review